Updates and Perspectives on Aquaporin-2 and Water Balance Disorders.

Abstract

Ensuring the proper amount of water inside the body is essential for survival. One of the key factors in the maintenance of body water balance is water reabsorption in the collecting ducts of the kidney, a process that is regulated by aquaporin-2 (AQP2). AQP2 is a channel that is exclusively selective for water molecules and impermeable to ions or other small molecules. Impairments of AQP2 result in various water balance disorders, including nephrogenic diabetes insipidus (NDI), which is a disease characterized by a massive loss of water through the kidney and consequent severe dehydration. Dysregulation of AQP2 is also a cause of water retention with hyponatremia in heart failure, hepatic cirrhosis, and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Antidiuretic hormone vasopressin is an upstream regulator of AQP2. Its binding to the vasopressin V2 receptor promotes AQP2 targeting to the apical membrane and thus enables water reabsorption. Tolvaptan, a vasopressin V2 receptor antagonist, is effective and widely used for water retention with hyponatremia. However, there are no studies showing improvement in hard outcomes or long-term prognosis. A possible reason is that vasopressin receptors have many downstream effects other than AQP2 function. It is expected that the development of drugs that directly target AQP2 may result in increased treatment specificity and effectiveness for water balance disorders. This review summarizes recent progress in studies of AQP2 and drug development challenges for water balance disorders.

• Authors: Yumi Noda, Sei Sasaki
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 23 (Nov 30 2021) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 34884753 (Publication Type: Journal Article, Review)

Chemical References

• AQP2 protein, human
• AVPR2 protein, human
• Antidiuretic Hormone Receptor Antagonists
• Aquaporin 2
• Receptors, Vasopressin

Topics

• Animals
• Antidiuretic Hormone Receptor Antagonists (therapeutic use)
• Aquaporin 2 (metabolism)
• Body Water (metabolism)
• Calcium Signaling
• Cytoskeleton (metabolism)
• Diabetes Insipidus, Nephrogenic (drug therapy, etiology, metabolism)
• Endocytosis
• Humans
• Kidney Tubules, Collecting (metabolism)
• Loss of Function Mutation
• Molecular Targeted Therapy
• Osmolar Concentration
• Phosphorylation
• Protein Transport
• Receptors, Vasopressin (chemistry, genetics, metabolism)
• Water-Electrolyte Balance